4//SEC Filing
Giovine Salvatore 4
Accession 0001415889-22-001793
CIK 0001840233other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 5:30 PM ET
Size
5.3 KB
Accession
0001415889-22-001793
Insider Transaction Report
Form 4
Giovine Salvatore
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2022-02-22+49,500→ 49,500 totalExercise: $12.66Exp: 2032-02-21→ Common Stock (49,500 underlying)
Footnotes (1)
- [F1]The option award was granted on February 22, 2022 and shall vest on March 1, 2022 with respect to 1/48th of the shares of common stock underlying the stock option and continue to vest in equal monthly installments thereafter until February 1, 2026.
Documents
Issuer
Xilio Therapeutics, Inc.
CIK 0001840233
Entity typeother
Related Parties
1- filerCIK 0001887790
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 5:30 PM ET
- Size
- 5.3 KB